Azarga clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses Azarga is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 7
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Alcon Research (6) · Aristotle University Of Thessaloniki (1)
Often tested with
Tested in the same studies.
Brimonidine Tartrate, Timolol Maleate Drug Combination (1) · Dorzolamide-timolol combination (1)
Studies
Open first, then newest update. How each study uses Azarga is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/TimololCompletedPhase 4Aristotle University Of ThessalonikiNCT00981786Written as Brinzolamide/timolol fixed combination drops added to travoprost
- Efficacy and Safety of Adding Azarga to Prostaglandin MonotherapyCompletedPhase 4Alcon ResearchNCT00966576Written as Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
- Patient Preference Comparison of AZARGA Versus COSOPT in Patients With GlaucomaCompletedPhase 4Alcon ResearchNCT01471158Written as Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
- Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin AmericaCompletedPhase 4Alcon ResearchNCT01518244Written as Brinzolamide/timolol maleate fixed combination
- Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionCompletedPhase 4Alcon ResearchNCT01111890Written as Azarga (brinzolamide 1% / timolol 0.5%)
- Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in BrazilTerminatedPhase 4Alcon ResearchNCT01514734Written as Brinzolamide/timolol maleate fixed combination
- ELAZOP Switching Study in KoreaCompletedPhase 4Alcon ResearchNCT01055366Written as Elazop (Azarga)